Skip to main content

Sanofi To Purchase Immune System-Focused Drugmaker Principia Biopharma For $3.7B

Sanofi SA will acquire Principia Biopharma Inc for $3.68 billion in cash, the two companies announced Monday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.